Solensia
Active substance
ATC code
Species
Cats
Indications
For the alleviation of pain associated with osteoarthritis in cats.
Dose to be administered and administration route
Subcutaneous use.
Avoid excessive shaking or foaming of the solution. Administer the entire content (1 ml) of the vial.
Dosage and treatment schedule:
The recommended dose is 1-2.8 mg/kg bodyweight, once a month.
Dose according to the dosing chart below.
|
Bodyweight (kg) of cat |
SOLENSIA (7 mg/ml) volume to be administered |
|
2.5 - 7.0 |
1 vial |
|
7.1 - 14.0 |
2 vials |
For cats greater than 7 kg, withdraw the full contents of two vials into the same syringe and administer as a single dose.
Adverse reactions
Cats:
|
Common (1 to 10 animals / 100 animals treated): |
localised skin reaction (e.g. alopecia, dermatitis, pruritus) |
|
Rare (1 to 10 animals / 10,000 animals treated): |
injection site reaction (e.g. pain and alopecia)1 |
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Anaphylaxis2 |
1 Mild.
2 In case of such reactions, appropriate symptomatic treatment should be administered.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the last section of the package leaflet for respective contact details.
